watch
Skystar Bio-Pharmaceutical Co.

Skystar Bio-Pharmaceutical Co.

Sector: Pharmaceutical Preparations Region: China


: | Nasdaq: SKBI


Skystar Bio-Pharmaceutical Co. engages in the research, development, production, marketing and sale of veterinary healthcare and medical care products. Its products include bio-pharmaceutical veterinary vaccine, veterinary medicines for poultry and livestock, feed additives, and micro-organism products. The company was founded on July 3, 1997 and is headquartered in Xi'an, China.

Investor Calendar

Latest Media

Warning! Third-party cookies must be enabled to view SlideShare presentations. ×

Having trouble?

Skystar BioPharmaceuticals (SKBI) Facilities Tour

Skystar Bio-Pharmaceutical Co. video

Skystar BioPharmaceuticals (SKBI) Facilities Tour

Skystar Bio-Pharmaceutical Co. video

Skystar's (NASDAQ:SKBI) Jingzhou Hubei Facility

Skystar Bio-Pharmaceutical Co. video

Skystar's (NASDAQ:SKBI) Huxian Facility

Executives

Weibing Lu, Chairman and Chief Executive Officer
Mr. Weibing Lu, Chief Executive Officer, received his Bachelor's degree in science from Wuhan University of Mapping Science and Technology (now known as Wuhan University) in 1985. In 1986, he was a teacher of College of Xian Geology. Mr. Lu received his Master's degree in Business Administration in 1999 from Xian University. Mr. Lu has vast experience in the biotechnology field and in enterprise management. In 1992, he founded the Xian Xingji Electronic Engineering Company and served as its Chairman and President until 1997. In 2002, he was awarded as the title of "Outstanding Enterpriser of Xian Feed Industry" and appointed as a director of Xian Institute of Feed Industry. In July 1997, he founded Xian Tianxing Science and Technology Development Co., Ltd. In December 2003, Xian Tianxing Science and Technology Development Co., Ltd., was reorganized and became Xian Tianxing Bio-pharmaceutical Co., Ltd. Since December 2003, Mr. Lu has served as Chairman of the Board and President of Xian Tianxing Bio-Pharmaceutical Co., Ltd.
Bing Mei, Chief Financial Officer
Mr. Mei is a seasoned Chief Financial Officer fluent in both English and Mandarin with over 20 years of diverse industry experience including technology services and industrial manufacturing businesses. Before joining the Company, Mr. Mei served as Chief Financial Officer of Avineon, Inc., a global technology company specializing in information technology, geospatial, and engineering services for the government and commercial industries. Prior to Avineon, Mr. Mei served as Controller of Arrowhead Global Solutions, Inc. (now Harris CapRock Communications), a global provider of satellite communications to remote and harsh environments. Previously, Mr. Mei served as Controllers of PICS, Inc. and Thompson Hospitality Corporation, a member of the Compass Group family of companies. Mr. Mei received a B.S. from Zhejiang University in Hangzhou, China, an M.A. from Bowie State University and an M.B.A. from The Fuqua School of Business at Duke University where he graduated with distinction as a Fuqua Scholar. Mr. Mei is a Certified Public Accountant in the State of Maryland, a Certified Management Accountant, a Certified Valuation Analyst, and a Certified Sarbanes Oxley Professional.
Wei Wen, Director and Vice General Manager
Mr. Wei Wen, Director, graduated from Xian University of Science and Industry in 1986. From 1990 to 1994, Mr. Wen was the manager of Sales Department of Xian Zhongtian Science and Technology Development Co., Ltd. Then, from 1994 to 1997, Mr. Wen served as Vice General Manager and Manager of Sales Department of Xian Xingji Electronic Engineering Company. In 1997, Mr. Wen was appointed as the Vice General Manager of Xian Tianxing Science and Technology Development Co., Ltd. which he served until December 2003. After the reorganization of the company in December 2003, Mr. Wen was appointed and continues to serve as Vice General Manager and the Secretary of the Board of Directors of Xian Tianxing Bio-Pharmaceutical Co., Inc.

News & Analysis